Loading…
Rossari Biotech (ROSSARI)₹424.95+0.09%Specialty Chemicals
At the end of the Sep 2026 quarter, Rossari Biotech's shareholders were: promoters 68.09%, FIIs 1.83%, DIIs 14.17%, public 15.91%. Promoter holding is unchanged on the quarter. FII holding is down 0.86 percentage points from 2.69% a year earlier. 0.00% of promoter shares were pledged. It had 86,659 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 68.29% | 68.27% | 68.27% | 68.22% | 68.14% | 68.13% | 68.13% | 68.13% | 68.10% | 68.10% | 68.09% | 68.09% |
| FIIs | 4.13% | 4.01% | 3.82% | 3.73% | 3.73% | 3.97% | 3.47% | 2.69% | 2.31% | 2.17% | 2.02% | 1.83% |
| DIIs | 18.04% | 17.72% | 16.85% | 17.32% | 17.45% | 17.57% | 17.82% | 18.16% | 18.23% | 18.19% | 14.62% | 14.17% |
| Public | 9.54% | 10.00% | 11.06% | 10.73% | 10.68% | 10.33% | 10.58% | 11.02% | 11.36% | 11.54% | 15.27% | 15.91% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 1,00,466 | 98,902 | 1,00,518 | 97,230 | 95,776 | 92,892 | 91,831 | 91,426 | 89,287 | 87,009 | 87,618 | 86,659 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Edward Menezes | Promoter | 29.15% | 0.00 |
| Sunil Srinivasan Chari | Promoter | 13.13% | 0.00 |
| Chari Family Trust in the name of Sunil Srinivasan Chari and Jyotishna Sunil Chari | Promoter | 9.17% | −0.01 |
| Uti Aggressive Hybrid Fund | DII | 6.38% | New |
| Rossari Biotech India Private Limited | Promoter | 5.40% | −0.01 |
| Jyotishna Sunil Chari | Promoter | 4.50% | 0.00 |
| Yash Sunil Chari | Promoter | 4.46% | 0.00 |
| Life Insurance Corporation of India | DII | 4.04% | 0.00 |
| Canara Robeco Mutual Fund A/C Canara Robeco Small Cap Fund | DII | 1.86% | −0.05 |
| Anita Menezes | Promoter | 1.80% | 0.00 |
| Bhupesh Kumar Lodha | Public | 1.09% | New |
| Mikhail Menezes | Promoter | 0.24% | 0.00 |
| Menezes Family Trust in the name of Edward Walter Menezes and Anita Menezes | Promoter | 0.20% | 0.00 |
| Uti-Flexi Cap Fund | DII | Exited | — |
| Motilal Oswal Small Cap Fund | DII | Exited | — |
Promoters held 68.09% of Rossari Biotech at the end of the Sep 2026 quarter, down 0.04 percentage points from 68.13% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 1.83% (down 0.19 percentage points from 2.02% a quarter earlier) and domestic institutions (DIIs) held 14.17% (down 0.45 percentage points from 14.62% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Rossari Biotech had 86,659 shareholders at the end of the Sep 2026 quarter, against 91,426 a year earlier.
Uti Aggressive Hybrid Fund (DII) held 6.38% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.